509 related articles for article (PubMed ID: 17459610)
1. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
Hsu A; Pawlicki T; Luxton G; Hara W; King CR
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
[TBL] [Abstract][Full Text] [Related]
2. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
4. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
[TBL] [Abstract][Full Text] [Related]
5. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
6. Practical aspects of inverse-planned intensity-modulated radiation therapy for prostate cancer: a radiation treatment planner's perspective.
Parker W; Patrocinio H
Can J Urol; 2005 Jun; 12 Suppl 2():48-52. PubMed ID: 16018834
[TBL] [Abstract][Full Text] [Related]
7. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
8. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.
Yuen J; Rodrigues G; Trenka K; Coad T; Yartsev S; D'Souza D; Lock M; Bauman G
Radiat Oncol; 2008 Jan; 3():1. PubMed ID: 18179695
[TBL] [Abstract][Full Text] [Related]
9. A comparison of forward and inverse planned conformal, multi segment and intensity modulated radiotherapy for the treatment of prostate and pelvic nodes.
Vaarkamp J; Adams EJ; Warrington AP; Dearnaley DP
Radiother Oncol; 2004 Oct; 73(1):65-72. PubMed ID: 15465148
[TBL] [Abstract][Full Text] [Related]
10. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
[TBL] [Abstract][Full Text] [Related]
11. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
12. Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans.
Siebers JV; Keall PJ; Wu Q; Williamson JF; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):422-33. PubMed ID: 16168835
[TBL] [Abstract][Full Text] [Related]
13. Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins.
Suzuki M; Nishimura Y; Nakamatsu K; Okumura M; Hashiba H; Koike R; Kanamori S; Shibata T
Radiother Oncol; 2006 Mar; 78(3):283-90. PubMed ID: 16564594
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences.
Muren LP; Wasbø E; Helle SI; Hysing LB; Karlsdottir A; Odland OH; Valen H; Ekerold R; Johannessen DC
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1034-41. PubMed ID: 18249502
[TBL] [Abstract][Full Text] [Related]
15. The potential for dose dumping in normal tissues with IMRT for pelvic and H&N cancers.
Reddy NM; Mazur AK; Sampath S; Osian A; Sood BM; Ravi A; Nori D
Med Dosim; 2008; 33(1):55-61. PubMed ID: 18262124
[TBL] [Abstract][Full Text] [Related]
16. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.
Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C
BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric effects of patient rotational setup errors on prostate IMRT treatments.
Fu W; Yang Y; Li X; Heron DE; Huq MS; Yue NJ
Phys Med Biol; 2006 Oct; 51(20):5321-31. PubMed ID: 17019041
[TBL] [Abstract][Full Text] [Related]
18. Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.
Rossi PJ; Schreibmann E; Jani AB; Master VA; Johnstone PA
Radiother Oncol; 2009 Mar; 90(3):353-8. PubMed ID: 18952307
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma.
van der Geld YG; van Triest B; Verbakel WF; van Sörnsen de Koste JR; Senan S; Slotman BJ; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1215-20. PubMed ID: 18954715
[TBL] [Abstract][Full Text] [Related]
20. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
Guckenberger M; Baier K; Richter A; Vordermark D; Flentje M
Radiat Oncol; 2008 Jan; 3():3. PubMed ID: 18190681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
